The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–251 of 251
Once-Daily and Twice-Daily Dosing of p-Aminosalicylic Acid Granules
Peloquin, C. A., Berning, S. E., Huitt, G. A., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.3.9807131 · Cited by 51
Use of Rifabutin in the Treatment of Pulmonary Tuberculosis
Grassi, C., & Peona, V. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_1.s50 · Cited by 50
Jones, B. E., OTAYA, M., Antoniskis, D., et al. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.6.7952606 · Cited by 50
Pharmacokinetic study of the interaction between rifampicin and ketoconazole
Doble, N., Shaw, R. G., Rowland-Hill, C., Lush, M., Warnock, D. W., & Keal, E. E. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/21.5.633 · Cited by 49
YUEN, A., WONG, S., TAM, C., CHAN, S., WEI, W., & LAU, S. (1997) · Otolaryngology - Head and Neck Surgery · doi:10.1016/s0194-5998(97)70323-1 · Cited by 48
Bachmann, K. A., & Jáuregui, L. (1993) · Xenobiotica · doi:10.3109/00498259309059384 · Cited by 48
Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin*
Kivistö, K. T., Villikka, K., Nyman, L. M., Anttila, M. I., & Neuvonen, P. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90055-8 · Cited by 47
Detention of Persistently Nonadherent Patients With Tuberculosis
Oscherwitz, T. (1997) · JAMA · doi:10.1001/jama.1997.03550100069041 · Cited by 46
Rifampin and Warfarin: A Drug Interaction
Romankiewicz, J. A., & EHRMAN, M. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-2-224 · Cited by 46
Moreira, A. L., Tsenova, L., Murray, P. J., et al. (2000) · Microbial Pathogenesis · doi:10.1006/mpat.2000.0382 · Cited by 46
Rifampin-Fluconazole Interaction in Critically ILL Patients
Nicolau, D. P., Crowe, H. M., Nightingale, C. H., & Quintiliani, R. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502901007 · Cited by 45
Bue, P. L., Cass, R., Lobo, D., Moser, K., & Catanzaro, A. (1999) · CHEST Journal · doi:10.1378/chest.115.1.218 · Cited by 45
Carbamazepine-Isoniazid Interaction
Block, S. H. (1982) · PEDIATRICS · doi:10.1542/peds.69.4.494 · Cited by 44
Apseloff, G., Foulds, G. H., LaBoy‐Goral, L., Willavize, S. A., & Vincent, J. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb00017.x · Cited by 43
Griffith, D. E., Brown, B. A., & Wallace, R. J. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.6.1321 · Cited by 43
Interaction between rifampin and levothyroxine
NOLAN, S. R., SELF, T. H., & NORWOOD, J. M. (1999) · Southern Medical Journal · doi:10.1097/00007611-199905000-00018 · Cited by 42
Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.
Robson, R., Begg, E., Atkinson, H., et al. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03669.x · Cited by 42
Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation.
Ochs, H., Greenblatt, D. J., & Knüchel, M. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02256.x · Cited by 41
Ethionamide-lnduced Goitrous Hypothyroidism
Drucker, D. J., EGGO, M. C., SALIT, I. E., & BURROW, G. N. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-837 · Cited by 40
Kivistö, K. T., Lamberg, T. S., & Neuvonen, P. J. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb00880.x · Cited by 40
Borin, M. T., Chambers, J. H., Carel, B. J., Freimuth, W. W., Aksentijevich, S., & Piergies, A. A. (1997) · Antiviral Research · doi:10.1016/s0166-3542(97)00011-9 · Cited by 39
Interaction of Isoniazid and Warfarin
Rosenthal, A. R., Self, T. H., Baker, E. D., & Linden, R. A. (1977) · JAMA · doi:10.1001/jama.1977.03280210069029 · Cited by 39
Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis
Wallis, R. S., Helfand, M. S., Whalen, C. C., Johnson, J. L., Mugerwa, R. D., Vjecha, M. J., Okwera, A., & Ellner, J. J. (1996) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(96)90049-0 · Cited by 38
Preventive Treatment of Untreated, Nonactive Tuberculosis in an Eskimo Population
Comstock, G. W., & Woolpert, S. F. (1972) · Archives of Environmental Health An International Journal · doi:10.1080/00039896.1972.10666182 · Cited by 37
Brown, L. S., Sawyer, R. C., Li, R., et al. (1996) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)84352-9 · Cited by 36
Cerebrospinal Fluid Pharmacokinetics of the Antituberculosis Drugs
Holdiness, M. R. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510060-00006 · Cited by 36
Carter, E. J., & Mates, S. (1994) · CHEST Journal · doi:10.1378/chest.106.6.1896 · Cited by 35
Lymph node tuberculosis: A comparison of treatments 18 months after completion of chemotherapy
Campbell, I. A., & Dyson, A. J. (1979) · Tubercle · doi:10.1016/0041-3879(79)90042-4 · Cited by 34
Rifampin and Ansamycin Interactions with Cyclosporine After Renal Transplantation
Vandevelde, C., Chang, A., Andrews, D. F., Riggs, W. K., & Jewesson, P. J. (1991) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1991.tb03603.x · Cited by 33
Gharaibeh, M. N., Gillen, L. P., Osborne, B., Schwartz, J. I., & Waldman, S. A. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb05785.x · Cited by 33
The Effect of Hemodialysis on Cycloserine, Ethionamide, Para-Aminosalicylate, and Clofazimine
Malone, R. S., Fish, D. N., Spiegel, D. M., et al. (1999) · CHEST Journal · doi:10.1378/chest.116.4.984 · Cited by 32
Rifampicin Treatment Greatly Increases the Apparent Oral Clearance of Qninidine
Damkier, P., Hansen, L. L., & Brøsen, K. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb02019.x · Cited by 32
DANIEL, N., Lounis, N., Ji, B., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9904090 · Cited by 31
Rifampin-Induced Nonresponsiveness of Giant Cell Arteritis to Prednisone Treatment
Carrie, F. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.13.1521 · Cited by 30
Tuberculous pleural effusions developing during chemotherapy for pulmonary tuberculosis.
Matthay, R. A., Neff, T. A., & Iseman, M. D. (1974) · PubMed · doi:10.1164/arrd.1974.109.4.469 · Cited by 30
Ethambutol in the Initial Treatment of Pulmonary Tuberculosis
Doster, B., Murray, F. J., Newman, R., et al. (2015) · American Review of Respiratory Disease · Cited by 30
Gisclon, L. G., Curtin, C. R., Fowler, C. L., Williams, R. R., Hafkin, B., & Natarajan, J. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04362.x · Cited by 28
Some observations on the genetics of isoniazid resistance in the tubercle bacilli.
David, H. L., & Newman, C. M. (1971) · PubMed · doi:10.1164/arrd.1971.104.4.508 · Cited by 28
Six-months versus nine-months chemotherapy for tuberculosis of lymphnodes: preliminary results
British Thoracic Society Research Committee (1992) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80142-3 · Cited by 28
Possible Interaction Between Disulfiram and Isoniazid
Whittington, H. G., & GREY, L. (1969) · American Journal of Psychiatry · doi:10.1176/ajp.125.12.1725 · Cited by 27
Kim, Y.-H., Cha, I., Shim, J.-C., et al. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606000-00010 · Cited by 22
Influence of rifampicin on thyroid gland volume, thyroid hormones, and antipyrine metabolism
Christensen, H. R., Simonsen, K., Hegedüs, L., Hansen, B. M., Døssing, M., Kampmann, J. P., & Hansen, J. M. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1210406 · Cited by 20
Interaction between saquinavir soft‐gel and rifabutin in patients infected with HIV
Moyle, G. J., Buss, N., Goggin, T., et al. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01631.x · Cited by 18
Acute psychotic reaction probably caused by ethionamide
Narang, R. K. (1972) · Tubercle · doi:10.1016/0041-3879(72)90031-1 · Cited by 18
Pharmacokinetics of Rifapentine in Patients with Varying Degrees of Hepatic Dysfunction
Keung, A., Eller, M. G., & Weir, S. J. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb05789.x · Cited by 18
Failure of oral contraceptive with rifampicin.
Kc, G., & My, A. (1981) · PubMed · Cited by 18
Isoniazid and antidepressants: is there cause for concern?
Judd, F. K., Mijch, A. M., Cockram, A., & Norman, T. R. (1994) · PubMed · Cited by 17
Six-month combination chemotherapy for cervical tuberculous lymphadenitis.
Cheung, W. L., Siu, K. F., & Ng, A. B. (1990) · PubMed · Cited by 15
Drug Treatment of Tuberculosis: I. Standard Chemotherapy
Crofton, J. (1960) · BMJ · doi:10.1136/bmj.2.5195.370 · Cited by 15
Lack of effect of fluconazole on the pharmacokinetics of rifampicin in AIDS patients
Jaruratanasirikul, S., & Kleepkaew, A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.5.877 · Cited by 12
Influence of gatifloxacin, a new quinolone antibacterial, on pharmacokinetics of theophylline
Niki, Y., Hashiguchi, K., Miyashita, N., et al. (1999) · Journal of Infection and Chemotherapy · doi:10.1007/s101560050026 · Cited by 10
Cited by
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Self-citationKornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Metadata
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02-15
- Volume
- 167
- Issue
- 4
- Pages
- 603-662
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2418210342
- Cited by
- 1,944
- References
- 251
- FWCI
- 59.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.